Topics

GITR agonism can be exploited in combination with checkpoint blockade to overcome immune refractoriness in solid tumors | http://go.nature.com/2UNVXqP  @sloan_kettering #Immunotherapypic.twitter.com/O2EeP6BjY8

13:05 EDT 29 Apr 2019 | Nature Publishing

GITR agonism can be exploited in combination with checkpoint blockade to overcome immune refractoriness in solid tumors | http://go.nature.com/2UNVXqP 

Original Article: GITR agonism can be exploited in combination with checkpoint blockade to overcome immune refractoriness in solid tumors | http://go.nature.com/2UNVXqP  @sloan_kettering #Immunotherapypic.twitter.com/O2EeP6BjY8

NEXT ARTICLE

More From BioPortfolio on "GITR agonism can be exploited in combination with checkpoint blockade to overcome immune refractoriness in solid tumors | http://go.nature.com/2UNVXqP  @sloan_kettering #Immunotherapypic.twitter.com/O2EeP6BjY8"

Quick Search